|
MIMAT0002177
|
Neuroblastoma (NB), MYCN amplified (MNA)
|
CHLA-136
|
Over-expression
|
|
|
MI0000438
|
Neuroblastoma (NB), MYCN amplified (MNA)
|
CHLA-136
|
Over-expression
|
|
|
MI0000070
|
Neuroblastoma (NB), MYCN amplified (MNA)
|
CHLA-136
|
Over-expression
|
|
|
MI0000069
|
Neuroblastoma (NB), MYCN amplified (MNA)
|
CHLA-136
|
Over-expression
|
|
|
MIMAT0023694
|
Brain Tumor, ATRT
|
CHLA-02-ATRT
|
Over-expression
|
|
|
MIMAT0023693
|
Brain Tumor, ATRT
|
CHLA-02-ATRT
|
Over-expression
|
|
|
MIMAT0002864
|
Brain Tumor, ATRT
|
CHLA-02-ATRT
|
Over-expression
|
|
|
MIMAT0026606
|
Brain Tumor, Medulloblastoma
|
CHLA-01-MED
|
Over-expression
|
|
|
MIMAT0002176
|
Acute Lymphoblastic Leukemia (ALL), Glucocorticoid (GC)-resistant ALL
|
CEM-C1 (GC-resistant)
|
Over-expression
|
|
|
MIMAT0027479
|
Acute Lymphoblastic Leukemia (ALL), Etoposide-resistant T-ALL
|
CEM/VM-1-5
|
Over-expression
|
|
|
MIMAT0000097
|
Acute Lymphoblastic Leukemia (ALL), "" Parent
|
CEM/C1
|
Over-expression
|
|
|
MIMAT0019974
|
Acute Lymphoblastic Leukemia (ALL), T-ALL
|
CEM/C1
|
Over-expression
|
|
|
MIMAT0000069
|
Acute Lymphoblastic Leukemia (ALL), "" Parent
|
CEM/C1
|
Over-expression
|
|
|
MIMAT0000765
|
Acute Lymphoblastic Leukemia (ALL), TAL1-positive T-ALL
|
CEM
|
Over-expression
|
|
|
MIMAT0018099
|
Hepatoblastoma, CD90+ (surface marker of liver cancer stem cells [LCSCs])
|
CD90+ HepG2
|
Over-expression
|
|
|
MI0014204
|
Acute Lymphoblastic Leukemia (ALL), "" Parent
|
CCRF-SB
|
Over-expression
|
|
|
MIMAT0001340
|
Acute Lymphoblastic Leukemia (ALL), T-ALL with high ST6GALI expression
|
CCRF-CEM/ADR
|
Inhibition of expression
|
|
|
MIMAT0002881
|
Acute Lymphoblastic Leukemia (ALL), T-ALL
|
CCRF-CEM (PTEN null)
|
Over-expression
|
|
|
MIMAT0023695
|
Acute Lymphoblastic Leukemia (ALL), TAL1-positive T-ALL
|
CCRF-CEM
|
Inhibition of expression
|
|
|
MIMAT0000097
|
Acute Lymphoblastic Leukemia (ALL), T-ALL
|
CCRF-CEM
|
Over-expression
|
|